Epidemiology of concomitant psoriasis and hidradenitis suppurativa (HS): Experience of a tertiary medical center - 14/09/15
Supported by the Department of Dermatology, Brigham and Women's Hospital. |
|
Disclosures: Dr Merola is an investigator for Amgen, Pfizer, and Biogen Idec; is a consultant for Biogen Idec; serves on the advisory board of Amgen, Eli Lilly, and Novartis; has a licensed outcome measure to Abbvie; and is a speaker for Abbvie. Dr Qureshi serves as a consultant for Abbvie, Amgen, Centers for Disease Control and Prevention, Janssen, Merck, Novartis, and Pfizer and is an investigator for Amgen. Drs Patel, Wright, and Vleugels and Mr Cohen have no conflicts of interest to declare. |
Vol 73 - N° 4
P. 701-702 - octobre 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?